 HAYWARD, Calif.--BUSINESS WIRE--Pulse Biosciences, Inc. Nasdaq: PLSE, a novel bioelectric medicine company commercializing the CellFX System powered by Nano-Pulse StimulationTM NPSTM technology, announced today it will report financial results for the fourth quarter and full year of 2021 after market close on Thursday, March 31, 2022. Company management will host a corresponding conference call beginning at 1:30pm Pacific Time. Investors interested in listening to the conference call may d 